166 related articles for article (PubMed ID: 1691986)
1. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene.
Kawajiri K; Nakachi K; Imai K; Yoshii A; Shinoda N; Watanabe J
FEBS Lett; 1990 Apr; 263(1):131-3. PubMed ID: 1691986
[TBL] [Abstract][Full Text] [Related]
2. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene.
Hayashi S; Watanabe J; Nakachi K; Kawajiri K
J Biochem; 1991 Sep; 110(3):407-11. PubMed ID: 1722803
[TBL] [Abstract][Full Text] [Related]
3. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population.
Kihara M; Kihara M; Noda K
Carcinogenesis; 1995 Oct; 16(10):2331-6. PubMed ID: 7586131
[TBL] [Abstract][Full Text] [Related]
4. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro.
Hamada GS; Sugimura H; Suzuki I; Nagura K; Kiyokawa E; Iwase T; Tanaka M; Takahashi T; Watanabe S; Kino I
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):63-7. PubMed ID: 7534543
[TBL] [Abstract][Full Text] [Related]
5. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
[TBL] [Abstract][Full Text] [Related]
6. Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population.
Tefre T; Ryberg D; Haugen A; Nebert DW; Skaug V; Brøgger A; Børresen AL
Pharmacogenetics; 1991 Oct; 1(1):20-5. PubMed ID: 1726950
[TBL] [Abstract][Full Text] [Related]
7. Human cytochrome P450IIE1 gene: DraI polymorphism and susceptibility to cancer.
Uematsu F; Kikuchi H; Motomiya M; Abe T; Ishioka C; Kanamaru R; Sagami I; Watanabe M
Tohoku J Exp Med; 1992 Oct; 168(2):113-7. PubMed ID: 1363974
[TBL] [Abstract][Full Text] [Related]
8. Individual differences in lung cancer susceptibility in relation to polymorphisms of P-450IA1 gene and cigarette dose.
Kawajiri K; Nakachi K; Imai K; Hayashi S; Watanabe J
Princess Takamatsu Symp; 1990; 21():55-61. PubMed ID: 2134690
[TBL] [Abstract][Full Text] [Related]
9. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes.
Hayashi S; Watanabe J; Kawajiri K
Jpn J Cancer Res; 1992 Aug; 83(8):866-70. PubMed ID: 1399823
[TBL] [Abstract][Full Text] [Related]
10. MspI polymorphism of the human CYP2E gene.
Uematsu F; Kikuchi H; Abe T; Motomiya M; Ohmachi T; Sagami I; Watanabe M
Nucleic Acids Res; 1991 Oct; 19(20):5797. PubMed ID: 1719479
[No Abstract] [Full Text] [Related]
11. CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil.
Sugimura H; Hamada GS; Suzuki I; Iwase T; Kiyokawa E; Kino I; Tsugane S
Pharmacogenetics; 1995; 5 Spec No():S145-8. PubMed ID: 7581485
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in CYP1A1 and CYP2D6 genes: possible association with susceptibility to lung cancer.
Hirvonen A; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Vainio H
Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):109-12. PubMed ID: 7908263
[TBL] [Abstract][Full Text] [Related]
13. p53 single nucleotide polymorphisms and bladder cancer.
Biroš E; Kalina I; Salagovic J; Habalová V; Hriv ák M; Valanský L
Neoplasma; 2000; 47(5):303-6. PubMed ID: 11130248
[TBL] [Abstract][Full Text] [Related]
14. An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population.
Watanabe J; Yang JP; Eguchi H; Hayashi S; Imai K; Nakachi K; Kawajiri K
Jpn J Cancer Res; 1995 Mar; 86(3):245-8. PubMed ID: 7744693
[TBL] [Abstract][Full Text] [Related]
15. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer.
Uematsu F; Kikuchi H; Motomiya M; Abe T; Sagami I; Ohmachi T; Wakui A; Kanamaru R; Watanabe M
Jpn J Cancer Res; 1991 Mar; 82(3):254-6. PubMed ID: 1673675
[TBL] [Abstract][Full Text] [Related]
16. Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.
Sugimura H; Caporaso NE; Shaw GL; Modali RV; Gonzalez FJ; Hoover RN; Resau JH; Trump BF; Weston A; Harris CC
Carcinogenesis; 1990 Sep; 11(9):1527-30. PubMed ID: 1976046
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
Nakachi K; Imai K; Hayashi S; Kawajiri K
Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis.
Avila JJ; Lympany PA; Pantelidis P; Welsh KI; Black CM; du Bois RM
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):106-12. PubMed ID: 9870923
[TBL] [Abstract][Full Text] [Related]
19. Application of two neutral MspI DNA polymorphisms in the analysis of hereditary protein C deficiency.
Reitsma PH; te Lintel Hekkert W; Koenhen E; van der Velden PA; Allaart CF; Deutz-Terlouw PP; Poort SR; Bertina RM
Thromb Haemost; 1990 Oct; 64(2):239-44. PubMed ID: 1702905
[TBL] [Abstract][Full Text] [Related]
20. Two MspI polymorphisms within the APC gene.
Cottrell S; Bodmer WF
Hum Mol Genet; 1992 Aug; 1(5):352. PubMed ID: 1284630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
